A Phase II Study of Single Agent Bortezomib in Patients with Metastatic Breast Cancer: A Single Institution Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II Study of Single Agent Bortezomib in Patients with Metastatic Breast Cancer: A Single Institution Experience

Published:2007-01 Issue:8 Volume:25 Page:733-737
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Engel Ryan H.,Brown Jennifer A.,Von Roenn Jamie H.,O'Regan Ruth M.,Bergan Raymond,Badve Sunil,Rademaker Alfred,Gradishar William J.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/07357900701506573

Reference32 articles.

1. Targeting Apoptosis Pathways in Cancer Therapy

2. The ubiquitin-proteasome pathway and proteasome inhibitors

3. Proteasome: an emerging target for cancer therapy

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer;British Journal of Cancer;2024-09-09

2. Identification and validation of a copper homeostasis-related gene signature for the predicting prognosis of breast cancer patients via integrated bioinformatics analysis;Scientific Reports;2024-02-07

3. CDS-DB, an omnibus for patient-derived gene expression signatures induced by cancer treatment;Nucleic Acids Research;2023-10-27

4. The ubiquitin–proteasome system in breast cancer;Trends in Molecular Medicine;2023-08

5. Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors;BioFactors;2023-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3